ImmuCell Corporation
NASDAQ:ICCC
3.53 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | ImmuCell Corporation |
Symbool | ICCC |
Munteenheid | USD |
Prijs | 3.53 |
Beurswaarde | 27,650,772 |
Dividendpercentage | 0% |
52-weken bereik | 3.34 - 5.59 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Michael F. Brigham |
Website | https://immucell.com |
An error occurred while fetching data.
Over ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)